DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Sternberg CN, de Mulder PH, Schornagel JH. et al.
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
J Clin Oncol 2001;
19: 2638-2646
We do not assume any responsibility for the contents of the web pages of other providers.